We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

140 hedge funds and large institutions have $792M invested in Intersect ENT, Inc in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,846% more call options, than puts

Call options by funds: $5.04M | Put options by funds: $259K

92% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 13

17% more capital invested

Capital invested by funds: $678M → $792M (+$114M)

16% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 44

9% more funds holding

Funds holding: 128140 (+12)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
140
Holders Change
+12
Holders Change %
+9.38%
% of All Funds
3.49%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
51
Reduced
44
Closed
13
Calls
$5.04M
Puts
$259K
Net Calls
+$4.78M
Net Calls Change
+$2.57M
Name Holding Trade Value Shares
Change
Change in
Stake
QI
51
QS Investors
New York
$2.07M -$41.1K -1,387 -2%
TA
52
Teachers Advisors
New York
$2.07M +$1.33K +45 +0.1%
CCMH
53
Cornerstone Capital Management Holdings
New York
$2.03M +$115K +3,900 +6%
FG
54
Formula Growth
Quebec, Canada
$1.84M -$888K -30,000 -34%
NFA
55
Nationwide Fund Advisors
Ohio
$1.77M +$70.4K +2,377 +4%
AMI
56
Amica Mutual Insurance
Rhode Island
$1.71M
CEP
57
Chicago Equity Partners
Illinois
$1.6M +$1.53M +51,530 New
Wells Fargo
58
Wells Fargo
California
$1.6M +$78.9K +2,666 +5%
TAM
59
Tiverton Asset Management
Delaware
$1.56M -$186K -6,300 -11%
AR
60
Advisory Research
Illinois
$1.45M +$1.38M +46,632 New
Jacobs Levy Equity Management
61
Jacobs Levy Equity Management
New Jersey
$1.42M +$265K +8,950 +25%
Russell Investments Group
62
Russell Investments Group
United Kingdom
$1.41M +$210K +7,101 +19%
Ameriprise
63
Ameriprise
Minnesota
$1.39M -$292K -9,872 -18%
Swiss National Bank
64
Swiss National Bank
Switzerland
$1.33M
USAA
65
United Services Automobile Association
Texas
$1.33M +$31.1K +1,050 +3%
Mackenzie Financial
66
Mackenzie Financial
Ontario, Canada
$1.31M +$1.25M +42,160 New
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$1.29M -$136K -4,609 -10%
BG
68
Bellevue Group
Switzerland
$1.28M -$1.75M -59,000 -59%
TRSOTSOK
69
Teachers Retirement System of the State of Kentucky
Kentucky
$1.27M +$95.5K +3,225 +9%
Citadel Advisors
70
Citadel Advisors
Florida
$1.21M -$780K -26,347 -40%
APFBOT
71
Amica Pension Fund Board of Trustees
Rhode Island
$1.05M
MLICM
72
Metropolitan Life Insurance Company (MetLife)
New York
$1.05M +$499K +16,873 +100%
HI
73
HBK Investments
Texas
$1.04M -$126K -4,245 -11%
HLA
74
Hamilton Lane Advisors
Pennsylvania
$983K -$148K -5,000 -14%
RhumbLine Advisers
75
RhumbLine Advisers
Massachusetts
$926K +$9.62K +325 +1%

XENT Hedge Fund Activity: Q3 2017 in Review

140 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2017, worth a combined $792M — up 17% from $678M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new XENT positions and 13 closed out — a net gain of 12 holders — while 51 added to existing stakes and 44 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $27.8M. The largest seller was Jennison Associates, cutting an estimated $18.3M.

  • 140 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2017, up from 128 in Q2 2017.
  • Funds reported $792M of Intersect ENT, Inc stock for Q3 2017, up 17% quarter-over-quarter.
  • 25 funds opened new Intersect ENT, Inc positions in Q3 2017 and 13 closed out, a net change of +12 holders.
  • The largest Intersect ENT, Inc buyer in Q3 2017 was Fidelity Investments, an estimated $27.8M added.
  • The largest Intersect ENT, Inc seller in Q3 2017 was Jennison Associates, an estimated $18.3M sold.

Based on aggregated 13F filings for Q3 2017.